Clinical Trial

Home Treatment for Individuals Suffering From Severe Addictive Disorders

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 28, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Home Treatment (HT) has been successfully implemented in adult psychiatry in several countries including Switzerland. Patients with addiction problems were generally excluded even if the latter was not the main diagnosis. On the other hand, community treatments have successfully been established for these individuals. The investigators have recently offered HT to persons with severe addictive disorders which was well accepted. The investigators intend to conduct a pilot study to prepare a large-scale study if successful. The investigators intend to compare HT to treatment as usual (regular inpatient treatment) on a specialized ward with respect to readmission rates during 6 months after discharge. The data show that 70.8% of all readmissions occur during the first 6 months. Therefore, a period of 6 months is considered an adequate time interval to sufficiently answer this pilot study's question.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-09-28; most recent amendment 2025-08-21.
Status change: Not Yet Recruiting → Recruiting 2024-03-27
Trial Details
NCT Number NCT05563363
Lead Sponsor Louise Penzenstadler
Conditions Substance Use Disorders
Enrollment 40 participants
Start Date 2022-12-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-28